Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)

Clinical trial NCT01062490 · COMPLETED

Trial details

NCT number: NCT01062490
Sponsor: medac GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2004-11-01
Primary completion: 2008-07-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.